Isabelle Bedrosian

General Surgery
210 Ashville Ave # 408
Cary, NC 27518

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 165 publications

American Society of Breast Surgeons, Society of Breast Imaging, and College of American Pathology 2026 Guidelines for the Management of Proliferative Lesions With Atypia and Lobular Carcinoma In Situ.

American Society of Breast Surgeons, Society of Breast Imaging, and College of American Pathology 2026 Guidelines for the Management of Proliferative Lesions With Atypia and Lobular Carcinoma In Situ.

Journal: JAMA surgery
Published: August 19, 2026

Standardization of postoperative adverse event reporting: A critical opportunity for improvement within the National Clinical Trials Network.

Standardization of postoperative adverse event reporting: A critical opportunity for improvement within the National Clinical Trials Network.

Journal: Cancer
Published: July 28, 2026

ASO Visual Abstract: Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.

ASO Visual Abstract: Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.

Journal: Annals of surgical oncology
Published: March 24, 2026

Risk of malignancy after diagnosis of radial sclerosing lesion without atypia.

Risk of malignancy after diagnosis of radial sclerosing lesion without atypia.

Journal: Breast cancer research and treatment
Published: March 09, 2026

Active monitoring versus surgical excision for atypical ductal hyperplasia.

Active monitoring versus surgical excision for atypical ductal hyperplasia.

Journal: Cancer prevention research (Philadelphia, Pa.)
Published: March 08, 2026

Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early-Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.

Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early-Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.

Journal: Annals of surgical oncology
Published: January 20, 2026

Radiation Therapy De-escalation in Breast Cancer Patients With Pathologic Complete Response: An Integrated Analysis Using Real-World and Simulated Data.

Radiation Therapy De-escalation in Breast Cancer Patients With Pathologic Complete Response: An Integrated Analysis Using Real-World and Simulated Data.

Journal: International journal of radiation oncology, biology, physics
Published: January 09, 2026

Axillary Management and Outcomes After Neoadjuvant Endocrine Therapy in the Randomized PELOPS Trial.

Axillary Management and Outcomes After Neoadjuvant Endocrine Therapy in the Randomized PELOPS Trial.

Journal: Annals of surgical oncology
Published: September 12, 2025

ASO Author Reflections: Omission of Routine Surgery for Atypical Ductal Hyperplasia: Are We Getting Closer?

ASO Author Reflections: Omission of Routine Surgery for Atypical Ductal Hyperplasia: Are We Getting Closer?

Journal: Annals of surgical oncology
Published: August 21, 2025

Axillary Management after Neoadjuvant Endocrine Therapy (NET).

Axillary Management after Neoadjuvant Endocrine Therapy (NET).

Journal: Annals of surgical oncology
Published: July 31, 2025

Implications of the COMET Trial for the Management of Atypical Ductal Hyperplasia.

Implications of the COMET Trial for the Management of Atypical Ductal Hyperplasia.

Journal: Annals of surgical oncology
Published: June 02, 2025

Targeting microRNA let-7b-5p-mediated aberrant androgen receptor signaling for prevention of hormone receptor-negative breast cancer.

Targeting microRNA let-7b-5p-mediated aberrant androgen receptor signaling for prevention of hormone receptor-negative breast cancer.

Journal: NPJ breast cancer
Published: May 30, 2025
Showing 1-12 of 165

Last Updated: 09/26/2026